Very excited to share our new paper just out in Science Translational Medicine.
Using human genetics and mouse models we show that G6PC2 is critical for controlling glucagon secretion, and suggest this enzyme as a potential drug target for diabetes treatment.

https://www.science.org/doi/epdf/10.1126/scitranslmed.adi6148